Market Overview - The Hong Kong stock market experienced a decline today, with the Hang Seng Index closing at 26,572.46 points, down 500.57 points, representing a drop of 1.85% [2] - The Hang Seng Technology Index also fell, closing at 5,812.80 points, down 168.50 points, a decrease of 2.82% [5] Sector Performance - Technology stocks faced widespread declines, with Baidu Group-SW (09888.HK) dropping over 7%, JD Group-SW (09618.HK) down over 6%, and Alibaba-W (09988.HK) falling over 4% [5] - The lithium battery sector saw significant losses, with Tianqi Lithium (09696.HK) down over 4% and Ganfeng Lithium (01772.HK) down over 3% [5] - Chinese brokerage stocks weakened, with CITIC Securities (06030.HK) declining over 4% [5] - Conversely, the innovative drug sector saw gains, with Gilead Sciences-B (01672.HK) rising over 15%. The innovative drug sector reported a 36% year-on-year revenue growth in Q3, with continued quarter-on-quarter growth [5] Capital Flow - After a small net sell-off of southbound funds yesterday, there was a return of capital today, with a cumulative net purchase of Hong Kong stocks reaching 12.8 billion HKD by the end of the trading day [6] Future Outlook - Western Securities noted that the reopening of the U.S. government and the return of liquidity from the Federal Reserve could lead to a significant reversal of previous pessimistic trading assumptions. This may provide a larger rebound space for risk assets that had previously declined due to tightened liquidity [8] - The report suggests that the Hong Kong market, particularly the Hang Seng Technology Index, may benefit from this shift in liquidity, potentially leading to a strong rebound [8] - The current effective investment strategy is to maintain a positive yet cautious approach, focusing on balanced allocation and avoiding chasing high prices, while being vigilant about external factors such as U.S. Federal Reserve policies and U.S.-China relations [8]
港股速报 | 港股全天走弱 南向资金回流抄底 创新药概念逆势走强
Mei Ri Jing Ji Xin Wen·2025-11-14 08:42